OptimizeRx (OPRX) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.25% |
| Dec 31, 2025 | 44.58% |
| Sep 30, 2025 | 68.54% |
| Jun 30, 2025 | 38.09% |
| Mar 31, 2025 | 1.43% |
| Dec 31, 2024 | 28.96% |
| Sep 30, 2024 | -33.93% |
| Jun 30, 2024 | -57.88% |
| Mar 31, 2024 | -109.18% |
| Dec 31, 2023 | -144.24% |
| Sep 30, 2023 | -78.10% |
| Jun 30, 2023 | -81.55% |
| Mar 31, 2023 | -105.83% |
| Dec 31, 2022 | -29.28% |
| Sep 30, 2022 | -42.94% |
| Jun 30, 2022 | -60.19% |
| Mar 31, 2022 | -33.40% |
| Dec 31, 2021 | 29.83% |
| Sep 30, 2021 | 16.58% |
| Jun 30, 2021 | 20.73% |
| Mar 31, 2021 | -12.02% |
| Dec 31, 2020 | 39.38% |
| Sep 30, 2020 | -32.07% |
| Jun 30, 2020 | -46.30% |
| Mar 31, 2020 | -82.53% |
| Dec 31, 2019 | -64.53% |
| Sep 30, 2019 | -46.47% |
| Jun 30, 2019 | 34.50% |
| Mar 31, 2019 | 16.80% |
| Dec 31, 2018 | -24.78% |
| Sep 30, 2018 | 29.03% |
| Jun 30, 2018 | -5.03% |
| Mar 31, 2018 | -31.39% |
| Dec 31, 2017 | -59.86% |
| Sep 30, 2017 | -42.77% |
| Jun 30, 2017 | -37.21% |
| Mar 31, 2017 | -24.23% |
| Dec 31, 2016 | 0.85% |
| Sep 30, 2016 | 9.44% |
| Jun 30, 2016 | -7.46% |
| Mar 31, 2016 | -8.52% |
| Dec 31, 2015 | -15.33% |
| Sep 30, 2015 | 16.80% |